BRIEF published on 05/07/2024 at 19:34, 1 year 11 months ago GenSight Biologics annonce la mise à disposition d'un prospectus pour la cotation de nouvelles actions sur Euronext Paris Euronext Paris Augmentation De Capital Thérapie Génique Prospectus Produits Biologiques GenSight
PRESS RELEASE published on 05/07/2024 at 19:29, 1 year 11 months ago Terms of availability of prospectuses GenSight Biologics announces availability of listing prospectus for new shares on Euronext Paris. The prospectus approved by AMF includes universal registration document, securities note, and summary Euronext Paris New Shares AMF Approval GenSight Biologics Listing Prospectus
PRESS RELEASE published on 05/07/2024 at 19:29, 1 year 11 months ago Modalités de mise à disposition de prospectus GenSight Biologics annonce la mise à disposition d'un prospectus pour l'admission d'actions nouvelles sur Euronext Paris. La société spécialisée dans les thérapies géniques pour les maladies neurodégénératives informe sur le processus Euronext Paris Prospectus GenSight Biologics Thérapies Géniques Maladies Neurodégénératives
Published on 04/18/2026 at 04:00, 1 day 3 hours ago Formation Metals Responds to OTC Markets Request on Recent Promotional Activity
Published on 04/18/2026 at 02:00, 1 day 5 hours ago AI/ML Innovations Announces Completion of Share Issuance
Published on 04/18/2026 at 01:35, 1 day 6 hours ago Medicure Announces Resignation of President and Chief Operating Officer
Published on 04/18/2026 at 01:00, 1 day 6 hours ago Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development
Published on 04/18/2026 at 00:00, 1 day 7 hours ago Redwood AI Announces Collaboration with Aidos Innovations, Aimed at Enhancing Public Safety Collaboration with B.C. Government, Canadian Federal and Local Law Enforcement Agencies to Tackle the Fentanyl Crisis in British Columbia
Published on 04/18/2026 at 00:05, 1 day 7 hours ago ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
Published on 04/17/2026 at 21:39, 1 day 10 hours ago Linedata Services: Mise à disposition du Document d’Enregistrement Universel 2025 incluant le Rapport Financier Annuel 2025
Published on 04/17/2026 at 20:33, 1 day 11 hours ago LLB General Meeting 2026 – Shareholders approve all proposals of the Board of Directors
Published on 04/17/2026 at 19:30, 1 day 12 hours ago KAP AG: REFINANCING CONCEPT AGREED; NEW SYNDICATED LOAN SECURES FLEXIBILITY FOR THE ONGOING TRANSFORMATION PROCESS
Published on 04/17/2026 at 20:30, 1 day 11 hours ago ALTAREA - Déclaration d’opérations sur actions propres
Published on 04/17/2026 at 19:00, 1 day 12 hours ago Cegedim : Publication du Document d’Enregistrement Universel 2025
Published on 04/17/2026 at 19:00, 1 day 12 hours ago Cegedim: Release of its 2025 Universal Registration Document
Published on 04/17/2026 at 17:45, 1 day 14 hours ago Carrefour announces the sale of its minority stake in CarrefourSA in Turkey to Aydın
Published on 04/17/2026 at 17:45, 1 day 14 hours ago Carrefour annonce la cession de sa participation minoritaire dans CarrefourSA en Turquie à Aydın
